Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
51,432,581
-
Share change
-
+1,583,520
-
Total reported value
-
$1,119,137,255
-
Price per share
-
$21.76
-
Number of holders
-
103
-
Value change
-
+$31,274,087
-
Number of buys
-
70
-
Number of sells
-
24
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2022
As of 30 Jun 2022 Vaxcyte, Inc. - COMMON STOCK (PCVX) had 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,432,581 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Abingworth LLP, VANGUARD GROUP INC, TPG GP A, LLC, BlackRock Inc., Medicxi Ventures Management (Jersey) Ltd, STATE STREET CORP, and Frazier Life Sciences Management, L.P..
This table shows 103 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.